Diseases of the adrenal cortex of dogs and cats.
Of cases of hyperadrenocorticism in small animals 80-85% are the result of adrenocortical hyperplasia. Middle-aged or older Poodles, Dachshunds, Boston Terriers and Boxers are most commonly affected, and cats rarely. Clinical signs include polydipsia, polyuria, alopecia, abdominal distension, lethargy, weakness, hepatomegaly, calcinosis cutis, testicular atrophy and anestrus. Hematologic and biochemical changes may include neutrophilia, lymphopenia, monocytosis, eosinopenia, increased blood levels of alkaline phosphatase, SGPT, cholesterol, Na and glucose, and decreased K and T4 levels. The high-dosage dexamethasone suppression test helps differentiate pituitary-dependent hyperadrenocorticism from that caused by adrenal tumors. The low-dosage dexamethasone suppression test, determination of plasma ACTH levels, and ACTH response test are additional diagnostic aids in the diagnosis of Cushing's disease. Medical treatment involves oral use of mitotane (o,p'-DDD) at 50 mg/kg/day for 7 days and prednisone or prednisolone at 0.05 mg/kg/day. Hypophysectomy has been used with only 5% mortality in cases of pituitary-dependent hyperadrenocorticism. Adrenalectomy is indicated in cases of adrenal neoplasia.
D000324:Adrenocorticotropic Hormone; D000818:Animals; D002371:Cat Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D002415:Cats; D003480:Cushing Syndrome / Q000175:diagnosis / Q000209:etiology / Q000628:therapy / Q000662:veterinary*; D003907:Dexamethasone; D004198:Disease Susceptibility; D004283:Dog Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D004285:Dogs; D005260:Female; D006801:Humans; D007016:Hypophysectomy / Q000662:veterinary; D008297:Male; D008939:Mitotane / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use
D008939:Mitotane; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D011241:Prednisone